Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

April 30, 2005

Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
DRUG

Esomeprazole (Nexium)

Trial Locations (40)

Unknown

Research Site, Phoenix

Research Site, Little Rock

Research Site, Wilmington

Research Site, Orlando

Research Site, Atlanta

Research Site, Park Ridge

Research Site, Indianapolis

Research Site, Iowa City

Research Site, Shreveport

Research Site, Boston

Research Site, Waltham

Research Site, Detroit

Research Site, Plymouth

Research Site, Saint Paul

Research Site, Jackson

Research Site, Binghamton

Research Site, Brooklyn

Research Site, Buffalo

Research Site, Johnson City

Research Site, New Hyde Park

Research Site, The Bronx

Research Site, Winston-Salem

Research Site, Cleveland

Research Site, Dayton

Research Site, Philadelphia

Research Site, Chattanooga

Research Site, Burlington

Research Site, Norfolk

Research Site, Mount Pearl

Research Site, Halifax

Research Site, Greater Sudbury

Research Site, Hamilton

Research Site, Oakville

Research Site, Scarborough Village

Research Site, Parkdale

Research Site, Lille

Research Site, Paris

Research Site, Tours

Research Site, Genova

Research Site, Roma

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY